Colleen G. Bilancia

Colleen G. Bilancia

Auto-generated profile, based on publicly available information

Colleen G. Bilancia

Bionano Genomics, Lineagen Division, Inc., San Diego, CA, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
KDKyle Davis
Kyle Davis
CBColleen G. Bilancia
Colleen G. Bilancia
MMMegan Martin
Megan Martin
Rena VanzoRena Vanzo
Rena Vanzo
MRMegan Rimmasch
Megan Rimmasch
MSMoises Serrano
Moises Serrano
To identify and prioritize candidate disease genes of the central nervous system (CNS) we created the Neurogenetic Systematic Correlation of Omics-Related Evidence (NeuroSCORE). We used five genome-wide metrics highly associated with neurological phenotypes to score 19,598 protein-coding genes. Genes scored one point per metric, resulting in a range of scores from 0-5. Approximately 13,000 genes were then paired with phenotype data from the Online Mendelian Inheritance in Man (OMIM) database. We used logistic regression to determine the odds ratio of each metric and compared genes scoring 1+ to cause a known CNS-related phenotype compared to genes that scored zero. We tested NeuroSCORE using microarray copy number variants (CNVs) in case-control cohorts, mouse model phenotype data, and gene ontology (GO) and pathway analyses. NeuroSCORE identified 8,296 genes scored ≥1, of which 1,580 are “high scoring” genes (scores ≥3). High scoring genes are significantly associated with CNS phenotypes (OR=5.5, p <2×10 −16 ), enriched in case CNVs, and enriched in mouse ortholog genes associated with behavioral and nervous system abnormalities. GO and pathway analyses showed high scoring genes were enriched in chromatin remodeling, mRNA splicing, dendrite development, and neuron projection. OMIM has no phenotype for 1,062 high scoring genes (67%). Top scoring genes include ANKRD17, CCAR1, CLASP1, DOCK9, EIF4G2, G3BP2, GRIA1, MAP4K4, MARK2, PCBP2, RNF145, SF1, SYNCRIP, TNPO2 , and ZSWIM8 . NeuroSCORE identifies and prioritizes CNS-disease candidate genes, many not yet associated with any phenotype in OMIM. These findings can help direct future research and improve molecular diagnostics for individuals with neurological conditions.

1 April 2021 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
JDJullianne Diaz
Jullianne Diaz
MRMegan Rimmasch
Megan Rimmasch
Rena VanzoRena Vanzo
Rena Vanzo
CBColleen Bilancia
Colleen Bilancia